2012
Etiology, assessment, and management of aromatase inhibitor-related musculoskeletal symptoms.
Park SH, Knobf MT, Sutton KM. Etiology, assessment, and management of aromatase inhibitor-related musculoskeletal symptoms. Clinical Journal Of Oncology Nursing 2012, 16: 260-6. PMID: 22641317, DOI: 10.1188/12.cjon.260-266.Peer-Reviewed Original ResearchConceptsAdjuvant endocrine therapyMusculoskeletal symptomsAromatase inhibitorsEndocrine therapyHormone-responsive breast cancerAvailable evidenceSevere musculoskeletal symptomsBest available evidenceAI therapyPostmenopausal womenSurvival benefitClinical trialsSymptom distressBreast cancerMusculoskeletal assessmentClinical decisionSymptomsTherapyEffective interventionsEffective management strategiesEtiologyWomenManagement strategiesPossible causesAssessment guidelines
2011
Lifestyle Interventions for Cardiovascular Risk Reduction in Women with Breast Cancer
Knobf MT, Coviello J. Lifestyle Interventions for Cardiovascular Risk Reduction in Women with Breast Cancer. Current Cardiology Reviews 2011, 7: 250-257. PMID: 22758626, PMCID: PMC3322443, DOI: 10.2174/157340311799960627.Peer-Reviewed Original ResearchConceptsBreast cancerCardiovascular diseaseLifestyle interventionCancer survivorsRisk factorsPhysical activityNon-modifiable cardiovascular risk factorsCardiovascular risk factorsCardiovascular risk reductionSurvivorship care plansCo-morbid illnessBreast cancer accountsBreast cancer survivorsCardiovascular disease riskRegular physical activityHealthy lifestyle behaviorsRoutine physical activityQuality of lifeSurvival benefitSmoking cessationCancer accountsLifestyle behaviorsWeight managementObservational studyCardiovascular fitness
2002
Carrying On
Knobf MT. Carrying On. Nursing Research 2002, 51: 9-17. PMID: 11822573, DOI: 10.1097/00006199-200201000-00003.Peer-Reviewed Original ResearchConceptsChemotherapy-induced premature menopauseEarly-stage breast cancerStage breast cancerBreast cancerPremature menopauseAdjuvant chemotherapyOvarian toxicityEarly-stage breast cancer treatmentMenopausal symptom distressOncology care providersQuality of survivalBreast cancer treatmentBreast cancer experienceMajority of womenOrgan system toxicityAdjuvant therapyNormal mensesSurvival benefitSymptom managementMean ageMidlife women's healthSymptom distressSystem toxicityCare providersMenopause